ATE243253T1 - Rezeptoren der wachstumsfaktoren aus fibroblasten - Google Patents
Rezeptoren der wachstumsfaktoren aus fibroblastenInfo
- Publication number
- ATE243253T1 ATE243253T1 AT91915163T AT91915163T ATE243253T1 AT E243253 T1 ATE243253 T1 AT E243253T1 AT 91915163 T AT91915163 T AT 91915163T AT 91915163 T AT91915163 T AT 91915163T AT E243253 T1 ATE243253 T1 AT E243253T1
- Authority
- AT
- Austria
- Prior art keywords
- domain
- fibroblasts
- receptors
- growth factors
- repeats
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54958790A | 1990-07-06 | 1990-07-06 | |
PCT/US1991/004745 WO1992000999A1 (en) | 1990-07-06 | 1991-07-03 | Fibroblast growth factor receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE243253T1 true ATE243253T1 (de) | 2003-07-15 |
Family
ID=24193610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91915163T ATE243253T1 (de) | 1990-07-06 | 1991-07-03 | Rezeptoren der wachstumsfaktoren aus fibroblasten |
Country Status (10)
Country | Link |
---|---|
US (1) | US6344546B1 (de) |
EP (2) | EP0538404B1 (de) |
JP (2) | JP3615220B2 (de) |
AT (1) | ATE243253T1 (de) |
AU (1) | AU662107B2 (de) |
CA (1) | CA2086425C (de) |
DE (1) | DE69133281T2 (de) |
DK (1) | DK0538404T3 (de) |
ES (1) | ES2204886T3 (de) |
WO (1) | WO1992000999A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6228609B1 (en) * | 1992-07-09 | 2001-05-08 | Systemix, Inc. | Soluble Flk-2 sequence |
JPH11512708A (ja) | 1995-09-11 | 1999-11-02 | オステオアルスリィティス サイエンシズ,インコーポレイテッド | 変形性関節炎を治療するためのプロテインチロシンキナーゼインヒビター |
US6214795B1 (en) | 1996-11-12 | 2001-04-10 | Praecis Pharmaceuticals, Inc. | Peptide compounds useful for modulating FGF receptor activity |
WO2000039311A1 (en) * | 1998-12-31 | 2000-07-06 | Advanced Research And Technology Institute | Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
US6657078B2 (en) * | 2001-02-07 | 2003-12-02 | Celanese International Corporation | Low energy carbonylation process |
WO2007014123A2 (en) * | 2005-07-22 | 2007-02-01 | Five Prime Therapeutics, Inc. | Compositions and methods of treating disease with fgfr fusion proteins |
PE20081250A1 (es) | 2006-11-28 | 2008-10-07 | Centelion | FUSIONES Fc CON RECEPTOR PARA FGF SOLUBLE MODIFICADAS, CON ACTIVIDAD BIOLOGICA MEJORADA |
JOP20190083A1 (ar) | 2008-06-04 | 2017-06-16 | Amgen Inc | بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها |
EP2318529B1 (de) | 2008-08-04 | 2017-10-18 | Five Prime Therapeutics, Inc. | Muteine in der sauren region der extrazellulären domäne von fgfr |
US9279013B2 (en) | 2008-10-10 | 2016-03-08 | Amgen Inc. | FGF-21 mutants comprising polyethylene glycol and uses thereof |
US20120052069A1 (en) | 2009-05-05 | 2012-03-01 | Amgen Inc | Fgf21 mutants and uses thereof |
CN107188950B (zh) | 2009-05-05 | 2021-09-28 | 安姆根有限公司 | Fgf21突变体及其用途 |
CA2764835A1 (en) * | 2009-06-17 | 2010-12-23 | Amgen Inc. | Chimeric fgf19 polypeptides and uses thereof |
WO2011034940A1 (en) | 2009-09-15 | 2011-03-24 | Five Prime Therapeutics, Inc. | Hair growth methods using fgfr4 extracellular domains |
ES2600631T3 (es) | 2009-11-13 | 2017-02-10 | Five Prime Therapeutics, Inc. | Uso de proteínas del dominio extracelular de FGFR1 para tratar cánceres caracterizados por mutaciones activadoras dependientes de ligando en FGFR2 |
US8372952B2 (en) * | 2009-12-02 | 2013-02-12 | Amgen Inc. | Binding proteins that bind to human FGFR1C, human β-klotho and both human FGFR1C and human β-klotho |
UA109888C2 (uk) | 2009-12-07 | 2015-10-26 | ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ | |
US8685931B2 (en) | 2009-12-17 | 2014-04-01 | Five Prime Therapeutics, Inc. | Hair growth methods using FGFR3 extracellular domains |
EP2569012A4 (de) | 2010-05-11 | 2013-10-30 | Aveo Pharmaceuticals Inc | Anti-fgfr2-antikörper |
AU2011329127B2 (en) | 2010-11-15 | 2015-09-03 | Five Prime Therapeutics, Inc. | FGFR1 extracellular domain combination therapies |
US8481038B2 (en) | 2010-11-15 | 2013-07-09 | Five Prime Therapeutics, Inc. | Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins |
US8951972B2 (en) | 2010-12-09 | 2015-02-10 | Five Prime Therapeutics, Inc. | FGFR1 extracellular domain combination therapies for lung cancer |
CA2855818A1 (en) | 2011-11-14 | 2013-05-23 | Five Prime Therapeutics, Inc. | A method of treating lung cancer having an fgfr1 gene amplification or fgfr1 overexpression |
US9925240B2 (en) | 2013-03-06 | 2018-03-27 | Genentech, Inc. | Methods of treating and preventing cancer drug resistance |
CN107073121A (zh) | 2014-06-13 | 2017-08-18 | 基因泰克公司 | 治疗及预防癌症药物抗性的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9001466D0 (en) * | 1990-01-23 | 1990-03-21 | Erba Carlo Spa | Extracellular form of the human fibroblast growth factor receptor |
WO1991000916A2 (en) * | 1989-07-06 | 1991-01-24 | The Regents Of The University Of California | Receptors for fibroblast growth factors |
-
1991
- 1991-07-03 DE DE69133281T patent/DE69133281T2/de not_active Expired - Lifetime
- 1991-07-03 EP EP91915163A patent/EP0538404B1/de not_active Expired - Lifetime
- 1991-07-03 DK DK91915163T patent/DK0538404T3/da active
- 1991-07-03 ES ES91915163T patent/ES2204886T3/es not_active Expired - Lifetime
- 1991-07-03 EP EP20030005707 patent/EP1403285A1/de not_active Ceased
- 1991-07-03 AT AT91915163T patent/ATE243253T1/de not_active IP Right Cessation
- 1991-07-03 WO PCT/US1991/004745 patent/WO1992000999A1/en active IP Right Grant
- 1991-07-03 AU AU84273/91A patent/AU662107B2/en not_active Expired
- 1991-07-03 CA CA002086425A patent/CA2086425C/en not_active Expired - Lifetime
- 1991-07-03 JP JP51370991A patent/JP3615220B2/ja not_active Expired - Lifetime
-
1994
- 1994-10-14 US US08/323,430 patent/US6344546B1/en not_active Expired - Lifetime
-
2003
- 2003-04-16 JP JP2003111330A patent/JP3996084B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69133281T2 (de) | 2004-05-06 |
WO1992000999A1 (en) | 1992-01-23 |
AU8427391A (en) | 1992-02-04 |
CA2086425A1 (en) | 1992-01-07 |
EP1403285A1 (de) | 2004-03-31 |
DE69133281D1 (de) | 2003-07-24 |
EP0538404B1 (de) | 2003-06-18 |
AU662107B2 (en) | 1995-08-24 |
EP0538404A4 (en) | 1993-05-26 |
EP0538404A1 (de) | 1993-04-28 |
JPH05508550A (ja) | 1993-12-02 |
JP3996084B2 (ja) | 2007-10-24 |
ES2204886T3 (es) | 2004-05-01 |
US6344546B1 (en) | 2002-02-05 |
CA2086425C (en) | 2006-01-17 |
JP2004041176A (ja) | 2004-02-12 |
DK0538404T3 (da) | 2003-10-13 |
JP3615220B2 (ja) | 2005-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE243253T1 (de) | Rezeptoren der wachstumsfaktoren aus fibroblasten | |
NO931955L (no) | Reseptorer for leukemiinhiberende faktor | |
ES2137931T3 (es) | Proteinas gdf-1 y uog-1. | |
NO964650D0 (no) | LAG-3 protein-opplöselige polypeptidfraksjoner, fremgangsmåte for fremstilling, teraupeutisk preparat og anti-idiotype antistoff | |
AR017510A1 (es) | Polinucleotido aislado o recombinante, vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para ladeteccion de un polinucleotido, compuesto de union, metodo de empleo del compuesto de union, polipeptido antigenico aislado o substancialmente puro, ymet | |
EP0871726A4 (de) | Multispezifische chimere rezeptoren | |
IT1242149B (it) | Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi | |
DK0618976T3 (da) | Syntetisk DNA-sekvens med forbedret insekticid virkning i majs | |
SG49061A1 (en) | A fungal bioassay for compounds that interact with functionally expressed heterologous G protein coupled receptors | |
CA2121798A1 (en) | Novel cytokine | |
CA2067031A1 (en) | Dna coding for human cell surface antigen | |
HUP0001650A2 (hu) | Javított expressziós vektorok | |
NO940736D0 (no) | DNA sekvenser som koder for gelonin polypeptid | |
DK0804577T3 (da) | cDNA, der koder en BMP type II receptor | |
DE69730841D1 (de) | C-typ lektine | |
NO922421L (no) | Collagenbindende protein, samt fremstilling derav | |
PT773999E (pt) | Receptor orfao or-1 pertencente a familia de receptores nucleares | |
ES8800353A1 (es) | Procedimiento de clonacion de factor humano viii-r. | |
DE69333284D1 (de) | Polypeptide mit serotoninerger (5ht5a) rezeptor-aktivität, für sie kodierende nukleinsäuren und ihre verwendung | |
DE60043664D1 (de) | Dungen davon | |
EP1140968A4 (de) | Dna-moleküle kodierende spleissvarianten des humanen melanocortin-1-rezeptorproteins | |
ATE410513T1 (de) | 'patched-2' protein aus wirbeltieren | |
DE69130675D1 (de) | Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum | |
NZ219611A (en) | Insecticidal peptide produced by recombinant dna techniques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0538404 Country of ref document: EP |
|
EELA | Cancelled due to lapse of time |